🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
596,13 USD
Máx. histórico
598,72
3 días
Split 2:1 del 23/09/2009
Caída desde máximo
-0,43%
Rango 52 semanas
430,02 – 609,99
Variación hoy
-0,43%
Cierre anterior
598,72
Rango de hoy
592,47 – 600,90
Volumen hoy
402.364
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,35 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/12/2025 | 495,13 | 496,54 | 486,51 | 487,25 | -1,80% | 2,03% | 348.500 |
| 30/12/2025 | 502,84 | 504,90 | 494,25 | 496,19 | -1,33% | 2,12% | 239.300 |
| 29/12/2025 | 508,98 | 509,85 | 500,79 | 502,90 | -0,84% | 1,78% | 256.600 |
| 26/12/2025 | 514,88 | 515,00 | 505,04 | 507,16 | -1,45% | 1,93% | 185.800 |
| 24/12/2025 | 512,89 | 516,08 | 508,83 | 514,64 | +0,82% | 1,41% | 194.600 |
| 23/12/2025 | 512,12 | 519,99 | 509,12 | 510,44 | -0,65% | 2,12% | 382.800 |
| 22/12/2025 | 517,13 | 519,65 | 510,64 | 513,79 | -0,65% | 1,74% | 411.000 |
| 19/12/2025 | 505,45 | 518,61 | 503,69 | 517,13 | +2,00% | 2,95% | 1.689.600 |
| 18/12/2025 | 507,08 | 513,57 | 498,76 | 507,00 | -0,77% | 2,92% | 614.800 |
| 17/12/2025 | 500,12 | 513,93 | 499,30 | 510,94 | +2,19% | 2,93% | 613.500 |
| 16/12/2025 | 497,17 | 502,77 | 491,76 | 500,00 | -0,06% | 2,21% | 488.800 |
| 15/12/2025 | 491,77 | 501,05 | 483,52 | 500,30 | +1,28% | 3,56% | 535.300 |
| 12/12/2025 | 491,00 | 496,73 | 488,75 | 493,99 | +1,12% | 1,63% | 638.800 |
| 11/12/2025 | 482,98 | 488,99 | 482,00 | 488,51 | +0,75% | 1,45% | 334.300 |
| 10/12/2025 | 479,62 | 486,23 | 477,54 | 484,86 | +1,78% | 1,81% | 371.900 |
| 09/12/2025 | 477,88 | 482,95 | 474,72 | 476,36 | -0,66% | 1,72% | 299.200 |
| 08/12/2025 | 488,97 | 489,99 | 474,59 | 479,51 | -2,00% | 3,15% | 468.600 |
| 05/12/2025 | 484,65 | 489,94 | 481,61 | 489,31 | +1,08% | 1,72% | 303.000 |
| 04/12/2025 | 480,63 | 486,46 | 477,56 | 484,10 | +0,65% | 1,85% | 630.700 |
| 03/12/2025 | 474,14 | 482,67 | 470,13 | 480,96 | +1,44% | 2,64% | 301.400 |
| 02/12/2025 | 480,14 | 484,24 | 473,51 | 474,14 | -1,21% | 2,23% | 309.000 |
| 01/12/2025 | 484,68 | 486,33 | 477,41 | 479,95 | -1,24% | 1,84% | 385.500 |
| 28/11/2025 | 490,25 | 490,30 | 484,35 | 486,00 | -0,50% | 1,21% | 168.100 |
| 26/11/2025 | 485,77 | 492,62 | 483,00 | 488,43 | +0,55% | 1,98% | 330.000 |
| 25/11/2025 | 480,86 | 486,20 | 471,05 | 485,77 | +1,80% | 3,15% | 298.400 |
| 24/11/2025 | 472,09 | 482,43 | 466,72 | 477,20 | +0,50% | 3,33% | 760.700 |
| 21/11/2025 | 473,37 | 477,64 | 468,51 | 474,82 | +0,02% | 1,93% | 444.500 |
| 20/11/2025 | 477,77 | 482,31 | 473,21 | 474,72 | -0,38% | 1,90% | 417.400 |
| 19/11/2025 | 473,82 | 480,90 | 472,10 | 476,54 | -0,01% | 1,86% | 466.700 |
| 18/11/2025 | 469,96 | 485,32 | 469,96 | 476,59 | +0,99% | 3,27% | 599.900 |